Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Long-Term Analysis Shows Boston Scientific’s Watchman Device Saves Money

Executive Summary

An analysis of pooled five-year data from the PROTECT AF and PREVAIL trials, show left-atrial appendage closure to prevent stroke in patients with atrial fibrillation is not only cost‐effective compared to treatment with warfarin and other anticoagulant drugs, but saves money over time.

You may also be interested in...



Conformal Medical Raises $85M To Advance Its Left Atrial Appendage Closure Device

The series C financing will support development of its CLAAS device, an alternative to anticoagulant drugs for atrial fibrillation patients.

Final Follow-Up Data Support Boston Scientific’s Watchman Stroke-Prevention Device

The final follow-up data from the CAP and CAP2 registries support left-atrial appendage closure with Watchman as an alternative to long-term anticoagulation in patients with nonvalvular atrial fibrillation.

Boston Scientific Delivers Q2 Sales Growth Across Its Product Lines

Boston Scientific Corp. posted revenue gains across its varied product categories, helped by strong performance in emerging markets.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT125322

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel